Croissance Share Price Target 2025: Can the Small-Cap Recover?
As of August 25, 2025, Croissance Ltd trades at ₹2.65, hovering near its 52-week low of ₹2.21 after a year of steep declines. The stock has lost over 50% in one year, reflecting weak fundamentals, negative sales growth, and no earnings (P/E unavailable). Despite this, the company’s P/B ratio stands at ~2.3×, suggesting the stock is still valued above its book. Analysts see limited upside, with one forecast suggesting a 2025 target of ₹8.30 under favorable conditions. The outlook remains uncertain, with investors closely watching support levels near ₹2.20 and resistance around ₹3.50.
Current Market Snapshot
-
Current Price: ₹2.65 (Aug 25, 2025)
-
52-Week Range: ₹2.21 – ₹6.50
-
Market Cap: ~₹18 crore
-
P/E Ratio: Not available (loss-making)
-
P/B Ratio: 2.2× – 2.4×
Fundamental Analysis
-
Sales Growth: Declined ~14% in last five years.
-
Profitability: Negative earnings, low ROE & ROCE.
-
Valuation: Stock trades above book despite weak financials.
-
Investor Sentiment: Currently bearish, small-cap volatility high.
Technical Analysis
-
Support Level: ₹2.20
-
Resistance Zone: ₹3.50 – ₹3.80
-
Trend: Bearish, but potential recovery if volumes rise.
Croissance Share Price Target 2025
-
Bearish Target: ₹2.00 – ₹2.50 (if fundamentals remain weak)
-
Base Case Target: ₹3.80 – ₹5.00 (if market stabilizes)
-
Bullish Target: ₹8.30 (under strong turnaround conditions)
Investor Takeaway
Croissance remains a high-risk, high-reward penny stock. Weak fundamentals limit confidence, but small-cap momentum could drive a short-term rebound. Investors should track quarterly updates, liquidity, and sector outlook before making decisions.
